Insecticides (India) Ltd reported a 7% revenue increase for FY26 to ₹2140 crore. However, consolidated profit for the year saw a slight decrease to ₹139.41 crore from ₹142.03 crore in FY25. The company cited a challenging environment and focus on premium products for the results.

Insecticides (India) Ltd Financial Results for FY 2026

Consolidated Revenue from Operations stood at ₹2140.01 Cr for FY 2026, an increase from ₹1999.95 Cr in FY 2025. Consolidated Profit for the year was ₹139.41 Cr, a slight decrease from ₹142.03 Cr in the previous year.

Standalone Revenue from operations was ₹2144.14 Cr in FY 2026, up from ₹2002.26 Cr in FY 2025. Profit for the year stood at ₹135.82 Cr, down from ₹139.76 Cr.

Reader Takeaway: Revenue growth driven by new products; margin focus continues amid profit dip.

What just happened

Insecticides (India) Ltd announced its financial results for the fiscal year 2026. The company reported an increase in revenue but a marginal decrease in profit compared to the previous fiscal year. This performance was achieved amidst a challenging business environment, with the company highlighting robust farmer acceptance of its new crop solutions.

Why this matters

The results indicate a strategic shift by the company towards margin-led growth through a premium product mix, rather than solely volume-driven expansion. While revenue shows positive momentum, the slight dip in profit suggests ongoing pressures or investments impacting the bottom line in the short term. The company's focus on R&D and new product launches is key to its future profitability.

The backstory

Insecticides (India) Ltd has been actively working on expanding its product portfolio. Over the last three years, it has launched more than 25 products. This fiscal year, it introduced five new products, including GRANUVIA™ in collaboration with Corteva Agriscience. The company also acquired Kaeros Research Limited in the latter half of FY25 to bolster its product range and supply chain.

What changes now

The company's strategic focus on premium products and innovation is expected to drive future margin improvements. Investors will be looking at how the integration of Kaeros Research Limited and the performance of the Sotanala manufacturing unit contribute to the company's operational efficiency and profitability. The company has also seen its credit profile improve, indicated by a credit rating upgrade.

Risks to watch

Key risks include intense competition and pricing pressures in basic pesticide formulations. The company's reliance on China for raw material imports and the unpredictable nature of monsoon patterns affecting agricultural demand remain significant concerns.

Peer comparison

While specific peer data for FY26 isn't provided, Insecticides (India) Ltd operates in the competitive agrochemical sector, facing similar challenges and opportunities as other players in terms of product development, raw material sourcing, and market demand fluctuations.

Context metrics (time-bound)

• Return on Capital Employed (ROCE) decreased to 14.44% in FY 2026 from 16.55% in FY 2025.
• Return on Net Worth (RONW) was 11.19% for FY 2026, down from 12.92% in FY 2025.
• Interest Coverage Ratio declined to 12.02x in FY 2026 from 29.3x in FY 2025, due to increased borrowings.
• Current Ratio improved to 1.96 in FY 2026 from 1.83 in FY 2025.
• Basic EPS stood at ₹46.68 in FY 2026, compared to ₹47.61 in FY 2025.

What to track next

Investors should monitor the successful integration of Kaeros Research Limited and the performance of its new product launches. Tracking the company's ability to navigate competitive pressures and its inventory management, especially concerning monsoon dependency, will be crucial.